HealthInvestor sits down with Adam Thorpe, Managing Director and UK head of health at Stax, for a deep dive into the opportunities in UK independent healthcare.

Worries that a crackdown on private provision of SEND care is imminent seem to be overstated.

The UK may see more companies list on the stock exchange (particularly the AIM market) if possible changes to the rules are implemented.